MetLife, Inc. (MET) is listed on NYSE and operates in the Insurance - Life industry (Financial Services sector).
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
| Rating | Analysts |
|---|---|
| Strong Buy | 0 |
| Buy | 25 |
| Hold | 8 |
| Sell | 0 |
| Strong Sell | 0 |
MetLife, Inc. is a global financial services company specializing in insurance, annuities, employee benefits, and asset management. It operates through five geographic segments: U.S.; Asia; Latin America; Europe, the Middle East, and Africa; and MetLife Holdings. The company provides a range of insurance products, including life, dental, disability, pet, accidental death and dismemberment, vision, and accident and health coverages. Additionally, MetLife offers prepaid legal plans and administrative services-only arrangements for employers. Its financial products include general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. MetLife also delivers pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products. The company supports postretirement benefits through life insurance products and funding agreements and offers solutions for nonqualified benefit programs for executives. Other offerings include fixed, indexed-linked, and variable annuities, pension products, savings products, and various life insurance options. Founded in 1863, MetLife is headquartered in New York, New York.
Over the past three fiscal years, the company has demonstrated robust growth and improved profitability. Revenue consistently increased at a 6.7% CAGR, rising from $67.7 billion in 2023 to $77.1 billion in 2025. This growth was accompanied by significant margin improvements; the gross margin expanded by 10.8pp to 36.4%, while the operating margin increased by 2.9pp to 6.0%. Despite some inconsistency, the net margin also improved by 2.1pp, reaching 4.4% by 2025. Earnings per share (EPS) showed an impressive, albeit inconsistent, growth of 62.8% CAGR, moving from $1.81 to $4.80, partly amplified by a 12.8% reduction in share count through buybacks, which enhanced per-share value creation. The company's cash generation was strong, with operating and free cash flows both consistently increasing at a 12.7% CAGR, reaching $18.1 billion by 2025. The free cash flow margin improved by 2.4pp to 23.5%, indicating efficient cash conversion. The company maintained a net cash position, with net debt decreasing slightly from -$1.81 billion to -$1.85 billion, reflecting a solid financial footing. However, liquidity remains a concern with a current ratio of 0.65, indicating potential challenges in meeting short-term obligations. Overall, the company's strategic focus on profitability and shareholder value is evident through its operational improvements and capital allocation decisions.
Recent developments for MetLife, Inc. focus on upcoming financial disclosures and significant institutional trading activity. MetLife is set to announce its first quarter 2026 results, as reported on April 8. This announcement is highly anticipated by investors and analysts, who are keen to assess the company's financial performance and future guidance. In related news, MetLife has advised shareholders to reject a "mini-tender" offer by Potemkin Limited, highlighting the company's stance on protecting shareholder interests. Institutional trading activity has been notable, with Boston Common Asset Management LLC holding $13.49 million in MetLife stock, while Providence Capital Advisors LLC acquired a new position valued at approximately $6.65 million. Arrowstreet Capital Limited Partnership increased its holdings significantly, now owning 417,515 shares valued at $33.58 million. Additionally, Thrivent Financial for Lutherans expanded its stake to 1,176,469 shares worth $96.91 million. These transactions indicate active interest and confidence from institutional investors in MetLife's prospects. In other updates, MetLife Investment Management originated $26 billion in private fixed income transactions in 2025, and Andrea Drasites was named head of Real Estate and Agricultural Finance, reflecting strategic moves in its investment management division.